PUBLICATIONS

Publications 2003-2005 - Current members of MPRC

1. Two-dimensional gel electrophoresis of synovial fluids: method for detection of candidate protein markers for osteoarthritis. H. Yamagiwa, G. Sarkar, M.C. Charlesworth, D.J. McCormick, M.E. Bolander. J Orthop Sci, 2003; 8: 482-490.
2. Selective tolerance to hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier. M. Boules, B. McMahon, R. Wang, L. Warrington, J. Stewart, S. Yerbury, A. Fauq, D. McCormick, E. Richelson. Brain Res, 2003; 987:39-48.
3. Three new hemoglobin variants with abnormal oxygen affinity: Hb Saratoga Springs (β40(C5) Lys _ Arg(β1)], HB Santa Clara (β97(FG4) His _ Asn] and HB Sparta (β104(G5) Phe _ Val]. J.D. Hoyer, J. Weinhold, E. Mailhot, D. Alter, D.J. McCormick, , K. Snow, K.S. Kubick, M.W. Holmes, V.F. Fairbanks. Hemoglobin, 2003; 27(4):235-41.
4. Advantages of Thermococcus kodakaraenis (KOD) DNA Polymerase for PCR-Mass Spectrometry Based Analyses. L.M. Benson, A.P. Null, and D.C. Muddiman, J Am Soc Mass Spectrom, 2003, 14, 601-604.
5. Mass Spectral Determination of Skeletal/Cardiac Actin Isofrom Rations in Cardiac Muscle. H.R. Bergen, III, K. Ajtai, T.P. Burghardt, A.I. Nepomuceno, and D.C. Muddiman, Rapid Commun Mass Spectrom, 2003, 17, 1467-1471.
6. Naturally Processed Measles Virus Peptide Eluted From Class II HLA-DRB1*03 Recognized by T. Lymphocytes From Human Blood. I.G. Ovsyannikova, K.L. Johnson, S. Naylor, D.C. Muddiman, and G.A. Poland, Virology, 2003, 312, 495-506.
7. Cancer Biomarkers: How Proteomics is Leading to the Discovery of New Markers. D.C. Muddiman, W.A. Cliby, H.R. Bergen, III, Clin Lab News, 2003, 29, 12-16.
8. Dual Electrospray Ionization Source for Confident Generation of Accurate Mass Tags Using Liquid Chromatography Fourier Transform Ion Cyclotron Resonance Mass Spectrometry. A.I. Nepomuceno, D.C. Muddiman, H.R. Bergen, III, J.R. Craighead, M.J. Burke, P.E. Caskey, and J.A. Allan, Anal Chem, 2003, 75, 3411-3418.
9. Enzymatic Strategies for DNA Characterization by Electrospray Ionization Mass Spectrometry. A.P. Null, L.M. Benson, and D.C. Muddiman, Rapid Commun Mass Spectrom, 2003, 17, 2699-706.
10. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques. J.F. Poduslo, G.L. Curran, J.A. Peterson, D.J. McCormick, A.H. Fauq, M.A. Khan, T.M. Wengenack. Biochemistry, 2004; 43:6064-6075.
11. Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. J.C. Flynn, D.J. McCormick, V. Brusic, Q. Wan, J.C. Panos, A.A. Giraldo, C.S. David, Y.M. Kong. Cell Immunol, 2004; 229:79-85.
12. Proteomics shows Hsp70 does not bind peptide sequences indiscriminately in vivo. M.E. Grossmann, B.J. Madden, F. Gao, Y.P. Pang, J. Carpenter, D.J. McCormick, C.Y. Young. Exp Cell Res, 2004; 297(1):108-17.
13. Identification and Characterization of Novel, Naturally Processed Measles Virus Class II HLA-DRB1 Peptides. I.G. Ovsyannikova, K.L. Johnson, D.C. Muddiman, R.A. Vierkant, G.A. Poland, J Virology, 2004, 78, 42-51.
14. A Method for Calculating 16O/18O Peptide Ion Ratios for the Relative Quantification of Proteomes K.L Johnson and D.C. Muddiman, J Am Soc Mass Spectrom, 2004, 15, 437-445.
15. Utility of Accurate Monoisotopic Mass Measurements to Confidently Identify Lambda Exonuclease Generated Single-Stranded Amplicons Containing 7-Deaza Analogs by Electrospray Ionization FT-ICR Mass Spectrometry., J.L. Frahm, C.J. Mason, and D.C. Muddiman, Inter J Mass Spectrom, 2004, 234, 79-87.
16. Discovery of Ovarian Cancer Biomarkers in Serum Using NanoLC Electrospray Ionization TOF and FT-ICR Mass Spectrometry. H.R. Bergen, III, G. Vasmatzis, W.A. Cliby, K.L. Johnson, A.L. Oberg and D.C. Muddiman, Dis Markers, 2003-2004, 19, 239-249.
17. Detection of Genetic Variants of Transthyretin by LC Dual Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry A.I. Nepomuceno, C.J. Mason, D.C. Muddiman, H.R. Bergen, III and S.R. Zeldenrust, Clin Chem, 2004, 50, 1535-1543.
18. Identification of Transthyretin Variants using Sequential Proteomic and Genomic Analysis H.R. Bergen, III, S.R. Zeldenrust, M.L. Butz, D.S. Snow, P.J. Dyck, P.J.B. Dyck, C.J. Klein, J.F. O'Brien, S.N. Thibodeau, and D.C. Muddiman, Clin Chem, 2004, 50, 1544-1552.
19. Informed use of proteolytic inhibitors in biomarker discovery H.R. Bergen, III, M.G. Klug, M.E. Bolander, D.C Muddiman, Rapid Commun Mass Spectrom, 2004, 18, 1001-1002.
20. Analysis of the Low Molecular Weight Fraction of Serum by LC-DualESI-FT-ICR Mass Spectrometry: Precision of Retention Time, Mass, and Ion Abundance K.L. Johnson, C.J. Mason, D.C. Muddiman, and J.E. Eckel, Anal Chem, 2004, 76(17), 5097-5103.
21. Thyroxine-binding antibodies inhibit T-cell recognition of a pathogenic thyroglobulin epitope. Y.D. Dai, P. Eliades, K.A. Carayanniotis, D.J. McCormick, Y.M. Kong, V. Magafa, P. Cordopatis, P. Lymberi, G. Carayanniotis. J Immunol, 2005; 174(5):3105-3110.
22. Proteomic analysis of mantle cell lymphoma by protein microarray. I.M. Ghobrial, D.J. McCormick, S.H. Kaufmann, A.A. Leontovich, D.A. Loegering, J. Eckel, N.T. Dai, K.L. Krajnik, M.J. Stenson, A. Novak, S. Ansell, T.E. Witzig. Blood, 2005; 105(9):3722-3730.
23. Mapping sites of protein phosphorylation by mass spectrometry utilizing a chemical-enzymatic approach: characterization of products from α-S1 casein phosphopeptides. D.J. McCormick, M.W. Holmes, D.C. Muddiman, B.J. Madden. J Proteome Res, 2005; 4(2):424-434.
24. Déjà vu all over again: SKIN-CAP is still available and still contains a high potency glucocorticosteroid D.L. Swanson, M.R. Pittelkow, L.M. Benson, A.M. Hawkridge, D.C. Muddiman, Archives Derm, 2005; 141(6):801-803.
25. Analysis of the low molecular weight fraction of serum by LC-dual ESI-FT-ICR mass spectrometry: precision of retention time, mass, and ion abundance. K.L. Johnson, C.J. Mason, D.C. Muddiman, J.E. Eckel. Anal Chem 2004; 76(17):5097-5103.
26. Effect of Post-Excitation Radius on Ion Abundance, Mass Measurement Accuracy, and Isotopic Distributions in Fourier Transform Ion Cyclotron Resonance Mass Spectrometry, A.M. Hawkridge, A.I. Nepomuceno, S.L. Lovik, C.J. Mason, D.C. Muddiman, Rapid Commun Mass Spectrom, 2005; 19(7):915-918.
27. Evaluation of Protein Depletion Methods for the Analysis of Total-, Phospho- and Glycoproteins in Lumbar Cerebrospinal Fluid, Y. Ogata, M.C. Charlesworth, D.C. Muddiman. J Proteome Res, 2005; 4(3):837-845.
28. Primary Trabecular Meshwork Cells Incubated in Human Aqueous Humor Differ from Cells Incubated in Serum Supplements M.P Fautsch, K.G. Howell, A.M. Vrabel, M.C. Charlesworth, D.C. Muddiman, D.H. Johnson, Invest Ophthalmol Vis Sci, 2005; 46(8):2848-2856.
29. Characterization of the Loop Proximity in Bacteriophage P22 Capsid Protein by Chemical Crosslinking S. Kang, A.M. Hawkridge, K.L. Johnson, D.C. Muddiman, P. Prevelige, J Proteome Res, 2005, in preparation.
30. Identification of class II HLA-DRB1*03-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry. K.L. Johnson, I.G. Ovsyannikova, G.A. Poland, D.C. Muddiman. J Proteome Res, 2005; 4(6):2243-2249.
31. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. A.M. Hawkridge, D.M. Heublein, H.R. Bergen, III, A. Cataliotti, J.C. Burnett, Jr., and D.C. Muddiman. Proc Natl Acad Sci U S A, 2005; 102(48):17442-17447.
32. Accurate mass precursor ion data and tendem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus. K.L. Johnson, I.G. Ovsyannikova, B.J. Madden, G.A. Poland, D.C. Muddiman. J Am Soc Mass Spectrom, 2005; 16(11):1812-1817.
33. Normalization of relative peptide ratios derived from in-gel digests: applications to protein variant analysis at the peptide level. H.R. Bergen, III, D.C. Muddiman, J.F. O'Brien, J.D. Hoyer. Rapid Commun Mass Spectrom, 2005; 19(19):2871-2877.